Petraschka M, Li S, Gilbert T L, Westenbroek R E, Bruchas M R, Schreiber S, Lowe J, Low M J, Pintar J E, Chavkin C
Department of Pharmacology, University of Washington School of Medicine, Box 357280, 1959 Pacific Avenue Northeast, Seattle, WA 98195-7280, USA.
Neuroscience. 2007 Jun 8;146(4):1795-807. doi: 10.1016/j.neuroscience.2007.03.029. Epub 2007 Apr 30.
Phosphorylation of specific sites in the second intracellular loop and in the C-terminal domain have previously been suggested to cause desensitization and internalization of the mu-opioid receptor (MOP-R). To assess sites of MOP-R phosphorylation in vivo, affinity-purified, phosphoselective antibodies were raised against either phosphothreonine-180 in the second intracellular loop (MOR-P1) or the C-terminal domain of MOP-R containing phosphothreonine-370 and phosphoserine-375 (MOR-P2). We found that MOR-P2-immunoreactivity (IR) was significantly increased within the striatum of wild-type C57BL/6 mice after injection of the agonist fentanyl. Pretreatment with the antagonist naloxone blocked the fentanyl-induced increase. Furthermore, mutant mice lacking MOP-R showed only non-specific nuclear MOR-P2-IR before or after fentanyl treatment, confirming the specificity of the MOR-P2 antibodies. To assess whether MOP-R phosphorylation occurs following endogenous opioid release, we induced chronic neuropathic pain by partial sciatic nerve ligation (pSNL), which caused a significant increase in MOR-P2-IR in the striatum. pSNL also induced signs of mu opioid receptor tolerance demonstrated by a rightward shift in the morphine dose response in the tail withdrawal assay and by a reduction in morphine conditioned place preference (CPP). Mutant mice selectively lacking all forms of the beta-endorphin peptides derived from the proopiomelanocortin (Pomc) gene did not show increased MOR-P2-IR, decreased morphine antinociception, or reduced morphine CPP following pSNL. In contrast gene deletion of either proenkephalin or prodynorphin opioids did not block the effects of pSNL. These results suggest that neuropathic pain caused by pSNL in wild-type mice activates the release of the endogenous opioid beta-endorphin, which subsequently induces MOP-R phosphorylation and opiate tolerance.
先前有研究表明,μ-阿片受体(MOP-R)的第二个细胞内环和C末端结构域中特定位点的磷酸化会导致其脱敏和内化。为了评估体内MOP-R的磷酸化位点,我们制备了针对第二个细胞内环中磷酸苏氨酸-180(MOR-P1)或包含磷酸苏氨酸-370和磷酸丝氨酸-375的MOP-R C末端结构域(MOR-P2)的亲和纯化的磷酸选择性抗体。我们发现,在野生型C57BL/6小鼠注射激动剂芬太尼后,纹状体内的MOR-P2免疫反应性(IR)显著增加。拮抗剂纳洛酮预处理可阻断芬太尼诱导的增加。此外,缺乏MOP-R的突变小鼠在芬太尼处理前后仅表现出非特异性的核MOR-P2-IR,这证实了MOR-P2抗体的特异性。为了评估内源性阿片类物质释放后MOP-R是否会发生磷酸化,我们通过部分坐骨神经结扎(pSNL)诱导慢性神经性疼痛,这导致纹状体内MOR-P2-IR显著增加。pSNL还诱导了μ阿片受体耐受性的迹象,表现为在尾撤离试验中吗啡剂量反应向右移动以及吗啡条件性位置偏爱(CPP)降低。选择性缺乏源自阿黑皮素原(Pomc)基因的所有形式β-内啡肽的突变小鼠在pSNL后未表现出MOR-P2-IR增加、吗啡镇痛作用降低或吗啡CPP降低。相比之下,脑啡肽原或强啡肽原阿片类物质的基因缺失并未阻断pSNL的作用。这些结果表明,野生型小鼠中由pSNL引起的神经性疼痛激活了内源性阿片类物质β-内啡肽的释放,随后诱导了MOP-R磷酸化和阿片类药物耐受性。